^Marx J. Rosen's emergency medicine : concepts and clinical practice. 6th. Philadelphia: Mosby/Elsevier. 2006: 2239. ISBN 978-0-323-02845-5. OCLC 58533794.
^Hutchison JS, Ward RE, Lacroix J, Hébert PC, Barnes MA, Bohn DJ, et al. Hypothermia therapy after traumatic brain injury in children. The New England Journal of Medicine. June 2008, 358 (23): 2447–56. PMID 18525042. doi:10.1056/NEJMoa0706930.
^Grunau BE, Wiens MO, Brubacher JR. Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review. Cjem. September 2010, 12 (5): 435–42. PMID 20880437. doi:10.1017/s1481803500012598. Dantrolene may also be associated with improved survival and reduced complications, especially in patients with extreme (≥ 42 °C) or severe (≥ 40 °C) hyperpyrexia
^Sharma HS (編). Neurobiology of Hyperthermia 1st. Elsevier. 2007: 175–177, 485 [19 November 2016]. ISBN 9780080549996. Despite the myriad of complications associated with heat illness, an elevation of core temperature above 41.0 °C (often referred to as fever or hyperpyrexia) is the most widely recognized symptom of this syndrome.